Santiago [Chile], February 6 (ANI/Xinhua): Chilean Health Minister Enrique Paris reported on Friday that 454,155 people have been vaccinated against COVID-19 in the country so far, as part of the mass vaccination plan that kicked off on Wednesday.
Jakarta [Indonesia], January 27 (ANI/Xinhua): Indonesian President Joko Widodo on Wednesday received his second injection of the COVID-19 vaccine developed by China's biopharmaceutical company Sinovac Biotech at the Presidential Palace in Jakarta.
Ankara [Turkey], January 20 (ANI): Turkey started mass vaccination against COVID-19 with China's 'Sinovac' vaccine but its orders for the vaccine suffered many delays, which led to the Turkish opposition questioning whether Ankara was being punished for dragging its feet in ratifying an e
Brasilia [Brazil], January 18 (ANI/Sputnik): The Brazilian Health Regulatory Agency (Anvisa) on Sunday approved the use of two vaccines against the coronavirus disease, developed by companies AstraZeneca and Sinovac.
Brasilia [Brazil], January 13 (ANI): The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government statement on Tuesday, which raised questions about the lack of transparency of Chinese-made vaccin
Jakarta [Indonesia], January 13 (ANI): The Indonesian President Joko Widodo received his first shot of the Chinese COVID-19 vaccine, Sinovac, on Wednesday, marking the launch of the country's mass immunization programme.
Jakarta [Indonesia], December 7 (ANI): Indonesia has received 1.2 million doses of a Covid-19 vaccine made by China's biopharmaceutical company Sinovac Biotech.
Ankara [Turkey], November 12 (ANI): Brazil's health regulator Anvisa on Wednesday (local time) announced the resumption of clinical trials of China's Sinovac COVID-19 vaccine.
Brasilia [Brazil], November 10 (ANI): Brazil's health regulator Anvisa said on Monday it has suspended clinical trials of China's Sinovac COVID-19 vaccine, following a "severe incident".
Dhaka [Bangladesh], October 13 (ANI): The clinical trial of an experimental Chinese COVID-19 vaccine developed by Sinovac Biotech in Bangladesh is now uncertain as the health ministry refused to co-financing the initiative as requested by the Chinese drugmaker.